Lee Shulman

Chief of the Division of Clinical Genetics

Feinberg School of Medicine of Northwestern University – Illinois, USA

Lee P. Shulman MD is the Anna Ross Lapham Professor in Obstetrics and Gynecology and Chief of the Division of Clinical Genetics at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois. He also serves as the Co-Director of the Cancer Genetics Program of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, the Director of the Northwestern Ovarian Cancer Early Detection and Prevention Program and the Medical Director of Insight Medical Genetics and Reproductive Genetics Innovations. Dr. Shulman is also an Adjunct Professor in the Department of Medicinal Chemistry and Pharmacognosy at the University of Illinois at Chicago College of Pharmacy. He is a Fellow of the American College of Obstetricians and Gynecologists and a Founding Fellow of the American College of Medical Genetics. Dr. Shulman is a member of numerous regional, national and international organizations that pertain to the health and care of women. His work has been recognized regionally and nationally; most recently, he was again included in the list of “Top Doctors” in Chicago (2007-17) and the United States (2005-17). He serves as an Editor of the European Journal of Contraception and Reproductive Health and is the Executive Editor of the Journal of Gynecologic Surgery. He also serves on the editorial boards of Prenatal Diagnosis, Contraception, Menopause, Climacteric and as a peer-reviewer for 45 other journals. Dr. Shulman served as Chair of the Board of Trustees of the Association of Reproductive Health Professionals from 2006-2008 and is currently the President-Elect of the Central Association of Obstetricians and Gynecologists and the Chairman of the Fetoscopy Working Group. A frequent contributor to the peer-reviewed and informational literature with over 200 peer-reviewed articles and over 60 book chapters, Dr. Shulman’s major research interests are in reproductive and cancer genetics, contraception, menopause, women’s healthcare advocacy and botanical interventions in women’s health.